Clinical Trials Sponsored by Vomaris Innovations

Total 1577 results

Baxter Healthcare Corporation
Synovis Surgical Innovations

Terminated

The Mechanism of Action of the Unite Biomatrix in Diabetic Foot Ulcer

Diabetic Foot Ulcers

United States
Leiden University Medical Center
Atrium Innovations

Completed

Diet and Aggression: Reducing Aggression Among Chronic Psychiatric Inpatients Through Dietary Supplementation

Psychiatric Hospitalization

Netherlands
University of Washington
Synovis Surgical Innovations

Completed

Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial

Hiatal Hernia

United States
AEterna Zentaris
SCRI Development Innovations, LLC

Completed

Study of Perifosine + Capecitabine for Colon Cancer Patients

Colon Cancer
Genentech, Inc.
SCRI Development Innovations, LLC

Completed

FOLFOX/Bevacizumab With Onartuzumab (MetMAb) Versus Placebo as First-Line Treatment in Patients With Metastatic Colorectal Cancer

Colorectal Cancer

United States
Baxter Healthcare Corporation
Synovis Surgical Innovations

Completed

Peri-Strips Dry (PSD) Veritas Collagen Matrix Staple Line Reinforcement for Colorectal Surgery

Colorectal Cancer

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Treatment Based on Molecular Profiling Diagnosis Carcinoma of Unknown Primary Site

Carcinoma

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

A Study of Rituximab and Bevacizumab in Patients With Follicular Non-Hodgkin's Lymphoma

Lymphoma, Follicular

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Paclitaxel/Carboplatin Plus Bevacizumab/Erlotinib in the First Line Treatment of Carcinoma of Unknown Primary Site

Neoplasm, Unknown Primary

United States
Baxter Healthcare Corporation
Baxter Innovations GmbH

Completed

Fibrin Sealant VH S/D 500 S-apr in Hepatic Resection

Bleeding (Oozing) in Hepatic Resection

Germany
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Irinotecan, Carboplatin, Bevacizumab in the Treatment of Patients With Extensive Stage Small Cell Lung Cancer

Carcinoma, Small Cell Lung

United States
SCRI Development Innovations, LLC
Genentech, Inc.

Completed

Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer

Lung Cancer | Carcinoma, Small Cell Lung

United States
Sound Wave Innovation CO., LTD.

Recruiting

A Pivotal Study of LIPUS-Brain in Patients With Early Alzheimer's Disease

Alzheimer Disease, Early Onset

Japan
Hopital Montfort
AFP Innovation Fund

Completed

Endocuff Enhanced Colonoscopy: Does it Improve Polyp Detection and Make Rectal Retroflexion Unnecessary

Colorectal Cancer | Colonic Polyps

Canada
GeNeuro Innovation SAS

Terminated

A Long-term Extension of Study GNC-401

Multiple Sclerosis

Sweden
Nordsjaellands Hospital
Innovation Fund Denmark

Completed

Catheter-based Peripheral Regional Anesthesia After Orthopedic Surgery to the Foot or Ankle (API-FOOT)

Postoperative Pain

Denmark
The Orthopaedic Research & Innovation Foundation

Active, not recruiting

Proximal Humerus Fractures: A Retrospective Analysis (PHFx)

Proximal Humeral Fracture

United States
Cellceutix Corporation

Completed

Bioequivalence and Pharmacokinetic Study of Prurisol™ and Abacavir Sulfate in Healthy Volunteers

Psoriasis

United States
Center for Social Innovation, Massachusetts

Completed

CSC OnDemand: An Innovative Online Learning Platform for Implementing Coordinated Specialty Care (CSCOnDemand)

Psychosis

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

A Study of JNJ-87704916, as Monotherapy and in Combination for Advanced Solid Tumors

Advanced Solid Tumors

United States
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer

Carcinoma, Non-small-Cell Lung

Korea, Republic of, Spain, United States, Germany
GeNeuro Innovation SAS

Completed

Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis (ProTEct-MS)

Multiple Sclerosis

Sweden
Bispebjerg Hospital
LEO Innovation Lab

Completed

Assessing the Efficacy of Image-guided Laser-assisted Enstilar® Delivery for Treatment of Psoriatic Nails (LAsED)

Nail Psoriasis

Denmark
Tate & Lyle
Biofortis Innovation Services

Completed

The Effects of Soluble Corn Fiber on Gastrointestinal Tolerance and Fecal Microbiome in Healthy Children

Gastrointestinal Tolerance

United States
GeNeuro Innovation SAS

Completed

Safety Study of GNbAC1 in Multiple Sclerosis Patients

Multiple Sclerosis

Switzerland
Cellceutix Corporation

Completed

Efficacy and Safety Study of Brilacidin to Treat Serious Skin Infections

Bacterial Infection | Skin Infection

United States
Nordsjaellands Hospital
Innovation Fund Denmark

Completed

Intra-individual Reproducibility in Nerve Block Duration

Anesthesia, Regional

Denmark
Healthcare Innovation Technology Lab
Bayer

Unknown

Hemophilia Mobile App Usability Pilot

Hemophilia

United States
Nordsjaellands Hospital
Innovation Fund Denmark

Completed

Local Anesthetic Concentration and Nerve Block Duration

Peripheral Nerve Block

Denmark
Nordsjaellands Hospital
Innovation Fund Denmark

Completed

The Effect of Local Anaesthetic Volume on Nerve Block Duration and Nerve Block Duration Variability

Postoperative Pain

Denmark
SCRI Development Innovations, LLC
Daiichi Sankyo, Inc.

Recruiting

A Study of U3-1402 (Patritumab Deruxtecan) in Subjects With Metastatic Breast Cancer

Metastatic Breast Cancer | Locally Advanced Breast Cancer

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Nivolumab Maintenance Therapy After Autologous Stem Cell Transplant in Hodgkin Lymphoma Pts at Relapse/Progression Risk

Hodgkin Lymphoma

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Withdrawn

Nivolumab for High-Risk MDS/AML Patients After Allogeneic Stem Cell Transplant With Post-Transplant Cyclophosphamide

Myelodysplastic Syndromes | Leukemia, Myeloid, Acute | Myelodysplastic Syndrome Acute Myeloid Leukemia

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma

Neuroendocrine Carcinoma
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Dose-ranging Study: Safety, Tolerability and Immunogenicity of INO-4500 in Healthy Volunteers in Ghana

Lassa Fever

Ghana
Inovio Pharmaceuticals
Coalition for Epidemic Preparedness Innovations

Completed

Safety, Tolerability and Immunogenicity of INO-4800 for COVID-19 in Healthy Volunteers

Coronavirus Infection

United States
SCRI Development Innovations, LLC
Genentech, Inc.; Amgen

Completed

Combination Chemotherapy and Rituximab With Pegfilgrastim Followed by Rituximab, in Large B-Cell Non-Hodgkin's Lymphoma

Non-Hodgkins Lymphoma

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

Ixabepilone and Cyclophosphamide as Neoadjuvant Therapy in HER-2 Negative Breast Cancer

Breast Cancer

United States
SCRI Development Innovations, LLC
Achieve Life Sciences

Completed

Phase II Trial of Carboplatin and Pemetrexed +/- OGX-427 in Untreated Stage IV Non-Squamous-Non-Small-Cell Lung Cancer (Spruce)

Non Squamous Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
Bristol-Myers Squibb

Completed

A Randomized Trial of Ixempra Versus Taxol in Adjuvant Therapy of Triple Negative Breast Cancer (TITAN)

Breast Cancer

United States, Puerto Rico
SCRI Development Innovations, LLC
Sanofi; GlaxoSmithKline; Novartis

Terminated

Cabazitaxel Plus Lapatinib as Therapy for HER2-Positive Metastatic Breast Cancer Patients With Intracranial Metastases

Metastatic Breast Cancer With Intracranial Metastases

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; OSI Pharmaceuticals

Completed

Randomized, Double-Blind Trial of Erlotinib/Pazopanib or Erlotinib/Placebo in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer

Non Small Cell Lung Cancer

United States
SCRI Development Innovations, LLC
GlaxoSmithKline; Aventis Pharmaceuticals

Completed

Docetaxel, Vinorelbine and Trastuzumab in the Treatment of Patients With Metastatic Her-2 Positive Breast Cancer

Breast Cancer
MEI Pharma, Inc.
SCRI Development Innovations, LLC

Completed

Dose Escalation Study of the Safety and Pharmacokinetics of ME-344 Single Agent for Refractory Solid Tumors (ME-344-001)

Solid Tumors

United States
SCRI Development Innovations, LLC
Novartis; Genentech, Inc.

Completed

Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma

Kidney Cancer

United States
SCRI Development Innovations, LLC
AstraZeneca; Aventis Pharmaceuticals

Completed

Chemotherapy Plus Gefitinib Followed by Chemotherapy, Radiation Therapy, and Gefitinib For Head and Neck Cancer

Head and Neck Cancer

United States
Queen's University
AFP Innovation Fund

Recruiting

Structural Mitral Valve Project

Mitral Regurgitation

Canada
Johnson & Johnson Enterprise Innovation Inc.

Recruiting

Confocal Laser Endomicroscopy Nodule Localization by Robotic Bronchoscopy (CLEAR)

Lung Neoplasms

United States
Interventional Cardiovascular Innovation Group,...

Not yet recruiting

Jordanian Coronary Artery Ectasia Registry (JoCAER)

Coronary Artery Ectasia
Jewish General Hospital
Exactis Innovation

Recruiting

TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence (TRICIA)

Breast Cancer

Canada

Clinical Trials Sponsored by Vomaris Innovations

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations